您好，欢迎访问山东省农业科学院文献资源数据库平台

New insight into the management of renal excretion and hyperuricemia: Potential therapeutic strategies with natural bioactive compounds

文献类型： 外文期刊

作者： Yang, Bendong 1 ; Xin, Meiling 1 ; Liang, Shufei 1 ; Xu, Xiaoxue 1 ; Cai, Tianqi 1 ; Dong, Ling 1 ; Wang, Chao 1 ; Wang, Meng 1 ; Cui, Yuting 1 ; Song, Xinhua 1 ; Sun, Jinyue 3 ; Sun, Wenlong 1 ;

作者机构： 1.Shandong Univ Technol, Sch Life Sci & Med, Zibo, Peoples R China

2.Shandong Qingyujiangxing Biotechnol Co Ltd, Zibo, Peoples R China

3.Shandong Acad Agr Sci, Inst Agrofood Sci & Technol, Key Lab Novel Food Resources Proc, Key Lab Agroprod Proc Technol Shandong Prov,Minist, Jinan, Peoples R China

关键词： hyperuricemia; urate transporters; natural products; chronic kidney disease; renal urate extraction

期刊名称：FRONTIERS IN PHARMACOLOGY （ 影响因子：5.988； 五年影响因子：6.455 ）

ISSN：

年卷期： 2022 年 13 卷

页码：

收录情况： SCI

摘要： Hyperuricemia is the result of increased production and/or underexcretion of uric acid. Hyperuricemia has been epidemiologically associated with multiple comorbidities, including metabolic syndrome, gout with long-term systemic inflammation, chronic kidney disease, urolithiasis, cardiovascular disease, hypertension, rheumatoid arthritis, dyslipidemia, diabetes/insulin resistance and increased oxidative stress. Dysregulation of xanthine oxidoreductase (XOD), the enzyme that catalyzes uric acid biosynthesis primarily in the liver, and urate transporters that reabsorb urate in the renal proximal tubules (URAT1, GLUT9, OAT4 and OAT10) and secrete urate (ABCG2, OAT1, OAT3, NPT1, and NPT4) in the renal tubules and intestine, is a major cause of hyperuricemia, along with variations in the genes encoding these proteins. The first-line therapeutic drugs used to lower serum uric acid levels include XOD inhibitors that limit uric acid biosynthesis and uricosurics that decrease urate reabsorption in the renal proximal tubules and increase urate excretion into the urine and intestine via urate transporters. However, long-term use of high doses of these drugs induces acute kidney disease, chronic kidney disease and liver toxicity. Therefore, there is an urgent need for new nephroprotective drugs with improved safety profiles and tolerance. The current systematic review summarizes the characteristics of major urate transporters, the mechanisms underlying the pathogenesis of hyperuricemia, and the regulation of uric acid biosynthesis and transport. Most importantly, this review highlights the potential mechanisms of action of some naturally occurring bioactive compounds with antihyperuricemic and nephroprotective potential isolated from various medicinal plants.

  • 相关文献
作者其他论文 更多>>
置顶
购物车
反馈

© 京ICP备09089781号-29 主办单位：山东省农业科学院文献资源数据库平台

学术资源： 中国农业科学院 农业专业知识服务系统 农科联盟资源共建共享平台 中国农业科技文献与信息服务平台 中国农业期刊集成服务平台